Literature DB >> 1909144

Secretory repertoire of HIV-infected human monocytes/macrophages.

R Esser1, H von Briesen, M Brugger, M Ceska, W Glienke, S Müller, A Rehm, H Rübsamen-Waigmann, R Andreesen.   

Abstract

Apart from lymphocytes, mononuclear phagocytes play an essential role as target cells for human immunodeficiency virus (HIV). Circulating blood monocytes (MOs) and tissue macrophages (M phi) may harbor and distribute the virus throughout the body. In addition, proinflammatory monokines [interleukin-1 (IL-1), IL-6, IL-8, tumor necrosis factor-alpha (TNF-alpha)] may contribute to the pathogenesis of HIV-mediated diseases. We have established a culture system on hydrophobic Teflon membranes for blood-borne MOs/M phi. Both freshly isolated MOs as well as MO-derived M phi could be infected with a monocytotropic HIV-1 isolate (HIV-1D117III) derived from a perinatally infected child. The virus production monitored by assay for viral antigen in cell-free supernatant is continuous for several weeks. We analyzed the stimulus response and the secretory repertoire of MOs/M phi early after infection with HIV as well as in long-term cultured, virus-replicating cells. Infected MOs/M phi respond to interferon-gamma more effectively than control cells as estimated from the release of neopterin. The response to lipopolysaccharide was regulated differently: whereas the proinflammatory cytokines IL-1, IL-6, IL-8 and TNF-alpha were up-regulated and even constitutively secreted upon infection, the production of the hematopoietin macrophage-colony-stimulating factor decreased. High levels of TNF-alpha and IL-1 might augment the infectibility of M phi by HIV in an autocrine manner. Our results may provide some explanation for the immunologic dysfunction, the hematopoietic failure and the chronic inflammatory disease occurring in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909144     DOI: 10.1159/000163649

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  12 in total

1.  Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.

Authors:  A R Bender; H von Briesen; J Kreuter; I B Duncan; H Rübsamen-Waigmann
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Increased levels of circulating cytokines with HIV-related immunosuppression.

Authors:  Fatma M Shebl; Kai Yu; Ola Landgren; James J Goedert; Charles S Rabkin
Journal:  AIDS Res Hum Retroviruses       Date:  2011-12-02       Impact factor: 2.205

3.  Dysregulated production of interleukin-8 in individuals infected with human immunodeficiency virus type 1 and Mycobacterium tuberculosis.

Authors:  S Meddows-Taylor; D J Martin; C T Tiemessen
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection.

Authors:  Brett D Shepard; Mona R Loutfy; Janet Raboud; Frank Mandy; Colin M Kovacs; Christina Diong; Michele Bergeron; Victoria Govan; Stacey A Rizza; Jonathan B Angel; Andrew D Badley
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

5.  Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles.

Authors:  L Buonaguro; M L Tornesello; R C Gallo; Franco M Marincola; G K Lewis; F M Buonaguro
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

6.  Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting.

Authors:  V Schäfer; H von Briesen; R Andreesen; A M Steffan; C Royer; S Tröster; J Kreuter; H Rübsamen-Waigmann
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

7.  Empyema thoracis in AIDS.

Authors:  R J Coker
Journal:  J R Soc Med       Date:  1994-02       Impact factor: 18.000

8.  CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.

Authors:  Vikram Mehraj; Rayoun Ramendra; Stéphane Isnard; Franck P Dupuy; Bertrand Lebouché; Cecilia Costiniuk; Réjean Thomas; Jason Szabo; Jean-Guy Baril; Benoit Trottier; Pierre Coté; Roger LeBlanc; Madéleine Durand; Carl Chartrand-Lefebvre; Ido Kema; Yonglong Zhang; Malcolm Finkelman; Cécile Tremblay; Jean-Pierre Routy
Journal:  Front Immunol       Date:  2019-02-21       Impact factor: 7.561

9.  Treatment of Virulent Mycobacterium tuberculosis and HIV Coinfected Macrophages with Gallium Nanoparticles Inhibits Pathogen Growth and Modulates Macrophage Cytokine Production.

Authors:  Seoung-Ryoung Choi; Bradley E Britigan; Prabagaran Narayanasamy
Journal:  mSphere       Date:  2019-07-24       Impact factor: 4.389

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.